HomeLab TestsPartial Thromboplastin Time (PTT) Test
Back to Lab Tests
Partial Thromboplastin Time (PTT) Test
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Lab Tests

Partial Thromboplastin Time (PTT) Test

The partial thromboplastin time (PTT) test measures how many seconds it takes for your blood to clot, helping to identify bleeding or clotting disorders.

What is a PTT test?

A partial thromboplastin time (PTT) test measures the time it takes for your blood to clot. Clotting is managed by proteins called coagulation factors. If these factors are missing, low, or malfunctioning, your blood may clot too slowly—leading to bleeding disorders like hemophilia—or too quickly, which can cause dangerous clots that lead to heart attack or stroke.

What is it used for?

The PTT test is used to:

  • Find the cause of unexplained bruising or bleeding.
  • Monitor patients taking heparin, a blood-thinning medication.
  • Assess the risk of bleeding before surgery.
  • Check for clotting issues related to autoimmune diseases like lupus or antiphospholipid syndrome (APS).

Why do I need a PTT test?

Your provider may order this test if you have:

  • Unexplained bleeding or bruising.
  • A history of blood clots, liver disease, or multiple miscarriages.
  • Symptoms of a clotting disorder, such as prolonged bleeding from minor cuts, joint pain/swelling, or signs of excessive clotting (pain, warmth, or swelling in limbs).

What do the results mean?

Results are measured in seconds.

Longer than normal clotting time

This may indicate:

  • Hemophilia A or B.
  • Liver disease or vitamin K deficiency.
  • Genetic disorders like Von Willebrand disease.
  • Excessive heparin use.
  • Certain types of leukemia or autoimmune diseases.

Faster than normal clotting time

This may indicate:

  • The early stage of disseminated intravascular coagulation (DIC).
  • High levels of clotting factors due to inflammation, pregnancy, or cancer.
  • Advanced cancer of the ovaries, colon, or pancreas.

Note: A result outside the normal range does not always indicate a medical condition, as test results can differ from how blood clots inside the body. Your provider will interpret these results alongside other clinical findings.

Frequently Asked Questions

The surgeon orders a PTT to ensure your blood clotting ability is within a safe range for surgery. A markedly prolonged PTT suggests a bleeding risk, which may lead the team to delay the operation, give clotting factor concentrates, or adjust any anticoagulant medication before the incision. A normal or only mildly elevated PTT usually allows the surgery to proceed as planned with standard precautions.
Heparin directly prolongs the PTT, so clinicians often ask you to hold the dose for a specific interval (usually 4–6 hours for subcutaneous heparin) before drawing blood, unless the test is meant to monitor therapeutic levels. Your lab report will note “heparin effect” if the medication was not held, and the result will be interpreted accordingly. Always follow your provider’s exact timing instructions.
mild, isolated elevation (e.g., 1–1.5 times the upper limit) is often nonspecific and may be due to transient factors such as recent illness, mild liver dysfunction, or laboratory variation. Your clinician will likely repeat the test, review your medication list, and assess for any hidden bleeding signs before initiating any therapy. Immediate treatment is usually not required unless you have a known bleeding disorder or are on anticoagulants.
During pregnancy, clotting factor levels rise, which can shorten the PTT slightly. A modestly low PTT in pregnancy is generally normal and reflects the hyper‑coagulable state that protects against hemorrhage during delivery. However, a markedly prolonged PTT would still warrant investigation for underlying disorders such as antiphospholipid syndrome, which can affect both maternal and fetal outcomes.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab